GlassScriptPhysician profile
Joshua D Arnold
NPI 1417070103
$2,942.48
in general payments reported to CMS, 2019-2025
10 companies · $331 in 2025
The $331 reported for 2025 was less than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $331 · 2020: $1,507 · 2021: $111 · 2022: $116 · 2023: $129 · 2024: $418 · 2025: $331.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $879.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $878.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| W. L. Gore & Associates, INC. | $2,059.37 | 2020-2025 | Gore Excluder Thoracoabdominal Branch Endoprosthesis, Excluder Conformable Aaa Endoprosthesis With Active Control, Gore Tag Conformable Thoracic Endoprosthesis |
| Medtronic Vascular, INC. | $254.85 | 2019-2020 | |
| Silk Road Medical, INC. | $242.01 | 2021-2023 | Enroute Transcarotid Stent, Enroute Transcarotid Neuroprotection System |
| Smith+Nephew, INC. | $121.91 | 2019 | |
| Lemaitre Vascular, INC. | $113.47 | 2021-2023 | Artegraft Vascular Graft, Albograft Polyester Vascular Graft, Pruitt F3 Carotid Shunt |
| Medtronic, INC. | $53.61 | 2024 | Abre, Hawkone |
| Endologix LLC | $43.88 | 2019 | |
| Abbott Laboratories | $23.50 | 2025 | Cardiomems |
| Boston Scientific Corporation | $15.11 | 2024 | |
| Cook Medical LLC | $14.77 | 2025 | Cook |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joshua Arnold listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.